FDA Announces New Recommendations for Acceptable Limits of Nitrosamine in Drugs
The FDA has released new guidance on acceptable intake limits for certain nitrosamines and how drug manufacturers should test for them.
Tag Archives: Valsartan
-
-
Plans to Remove Potentially Carcinogenic Contaminants from Januvia, Janumet Outlined By Merck
Merck indicates it will remove nitrosamine contaminants from Januvia and Janumet by the end of 2023.
-
Valsartan NDMA Lawsuits Cleared To Move Forward, After Motion for Reconsideration Rejected
A federal judge has cleared Valsartan NDMA lawsuits to proceed after rejecting a call by defendants to reconsider the admissibility of plaintiffs' expert witnesses following the recent dismissal of Zantac…
-
Discovery of Cancer-Causing Chemicals in Zantac, Sunscreen and Other Products Highlights FDA Failures: Bloomberg
A Bloomberg report highlights how the independent laboratory, Valisure, has consistently discovered dangerous, potentially cancer-causing chemicals in products like Zantac and sunscreen before the FDA.
-
Nitrosamines Problems Are More Widespread in Drugs Than FDA Anticipated: Report
The FDA has been caught off-guard by the number of drugs being recalled for nitrosamine contamination and is likely to update a 2020 guidance to better address the problem according…
-
Potentially Cancer-Causing Contaminant Found In Januvia: FDA
Some batches of Januvia, a diabetes drug, contain high levels of nitrosamines which could increase cancer risks, the FDA warns.
-
Valsartan Settlement Masters Appointed To Advance Negotiations in MDL
Two former district judges have been appointed as valsartan settlement special masters to help bring about a resolution to the litigation.
-
Accuretic Recall Announced In Canada Over Nitrosamine Contamination In Another Pfizer Hypertension Drug
Canadian health regulators have announced an Accuretic recall, indicating the Pfizer hypertension drug contains levels of cancer-causing chemicals above the acceptable amounts.
-
Extended Use of Valsartan and Other Angiotensin-Receptor Blockers May Increase Cancer Risk: Study
Valsartan and similar hypertension drugs may carry an increased risk of cancer with long-term use, according to the findings of a new study.
-
Generic Metformin Recall Issued Over NDMA Contamination
Dozens of batches of generic metformin are being recalled due to the presence of NDMA; a cancer-causing chemical byproduct which has led to numerous drug recalls in recent years.
